CNCE Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 bal. 2024 @ 23:00):

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases...

Stats
Šios dienos apimtis	10.73M
Vidutinė apimtis	0.00
Rinkos kapitalizacija	401.95M
EPS	$0 ( 2023-08-02 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.64
ATR14	$0.231 (2.76%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-06	Van Heek Christi	Sell	25 651	Common Stock
2023-03-06	Van Heek Christi	Sell	16 400	Common Stock
2023-03-06	Van Heek Christi	Sell	25 000	Stock Option (Right to Buy)
2023-03-06	Van Heek Christi	Sell	10 000	Stock Option (Right to Buy)
2023-03-06	Van Heek Christi	Sell	10 000	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 100 transactions
Buy: 0 \| Sell: 4 463 235

Tūris Koreliacija

Ilgas: 0.24 (neutral)

Trumpas: -0.57 (weak negative)

Signal:(66.67) Neutral

Concert Pharmaceuticals Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
NNOX	0.949
NERV	0.942
TYHT	0.942
MESA	0.94
RVNC	0.935
IDYA	0.932
PIRS	0.929
CELH	0.928
LIXT	0.928
MBINO	0.927

10 Labiausiai neigiamai susiję koreliacijos
TWKS	-0.963
FNWB	-0.958
HMST	-0.951
TCPC	-0.949
UPLD	-0.948
INFI	-0.942
EYE	-0.941
VNET	-0.94
SABRP	-0.939
TBNK	-0.938

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Concert Pharmaceuticals Koreliacija - Valiuta/Žaliavos

0.81
( strong )

0.84
( strong )

-0.59
( weak negative )

0.62
( weak )

0.13
( neutral )

-0.41
( neutral )

Concert Pharmaceuticals Finansinės ataskaitos

Annual	2021
Pajamos:	$32 578.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-0.00233

FY	2021
Pajamos:	$32 578.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-0.00233

FY	2020
Pajamos:	$7.90M
Bruto pelnas:	$7 902.00 (0.10 %)
EPS:	$-2.40

FY	2019
Pajamos:	$1.08M
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-3.29

Financial Reports:

No articles found.

Concert Pharmaceuticals

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.